Insights into the Influences of Carboxymethyl-β-Cyclodextrin on DNA Formulations Characteristics and Gene Transfection Efficiency

Author(s): Hassan Elsana, Svetlana Mysina, Eman Ali Elkordy, Jane Carr-wilkinson, Amal Ali Elkordy*.

Journal Name: Current Drug Delivery

Volume 15 , Issue 6 , 2018

Become EABM
Become Reviewer

Graphical Abstract:


Background: Gene therapy is an expanding field and it can treat genetic and acquired diseases.

Objective: It was found that formulations with DNA: CM-β–CD (Carboxymethyl-beta-cyclodextrin): Pluronic-F127 1:3:3 and 1:3 DNA: CM-β–CD are the most stable formulations indicating high incorporation of DNA within CM-β –CD.

Method: Gel electrophoresis revealed DNA with low CM-β –CD concentration has formed a more stable complex. Samples 1:3 DNA: CM-β–CD and 1:3:3 DNA: CM-β–CD: Pluronic-127 show no DNA fragment, suggesting good condensation of DNA inside cyclodextrin cavity.

Results: This was confirmed by fluorescence data where fluorescence intensity was reduced for samples DNA: CM-β–CD 1:3. Overall, the findings showed that Carboxymethyl-beta-cyclodextrin (as a novel non-viral gene vector) was able to provide condensation and protection to the DNA, with and without Pluronic-F127, at low concentration.

Conclusion: pDNA/CM-β–CD complex has not only shown to be able to transfect COS 7 and SHSY5Y cell lines, but it gives a higher transfection efficiency than that produced by the TransIT-LT1 commercial transfection reagent.

Keywords: pDNA, Carboxymethyl-β-cyclodextrin, freeze drying, transfection, gel electrophoresis, gene therapy.

Rights & PermissionsPrintExport Cite as

Article Details

Year: 2018
Page: [867 - 878]
Pages: 12
DOI: 10.2174/1567201815666180226115503
Price: $65

Article Metrics

PDF: 19
PRC: 1